Molecular Diagnostic Pathology

Molecular pathology evaluation is becoming increasingly integrated into the practice of anatomic pathology and laboratory medicine. The integration of molecular and genomic pathology into pathology practice is conspicuous in oncology, where definition of molecular pathways important for specific tumors has enabled development of drugs to target these pathways, and companion tests to predict which tumors are likely to respond to these targeted agents, as well as in inherited and infectious diseases and disorders. The mission of the Molecular Diagnostic Pathology SIG is to synergize the efforts of basic, translational, and clinical science researchers to increase our understanding of molecular pathways and develop diagnostic, prognostic, and therapeutic applications.

The objectives of the Molecular Diagnostic Pathology SIG are to:

  1. Identify a community of scientists with a common interest in molecular pathology and application to diagnostics, prognostics, and therapeutics.
  2. Provide a forum for the dissemination of information about molecular pathology and molecular markers of disease.
  3. Through workshops and webinars, facilitate the identification and communication of new research in molecular pathology applications.
  4. Engage pre-doctoral students, post-doctoral trainees, and academically oriented house staff in molecular diagnostic approaches.


ASIP Members are invited to participate in the Molecular Diagnostic Pathology SIG Listserv. Please email to have your name and email address added to the listserv.

To send a message to the Molecular Diagnostic Pathology SIG Listserv, send your email to Please note that you must be a member of this listserv in order to send and receive messages.

Please direct all questions to: Lisa McFadden (240) 283-9712.


Gregory Tsongalis

Gregory Tsongalis, PhD
Dartmouth-Hitchcock Heaklh System


Andrei Turtoi

Andrei Turtoi, PhD
Montpellier Cancer Research Center